Pharmaceutical

Huadong enters licence deal for MC2 Therapeutics’ Wynzora cream

Huadong has entered into an agreement to acquire licence rights for MC2 Therapeutics’ Wynzora cream in Greater China.

Sep 1, 2023 - 20:00
Huadong enters licence deal for MC2 Therapeutics’ Wynzora cream
Huadong has entered into an agreement to acquire licence rights for MC2 Therapeutics’ Wynzora cream in Greater China.
Read the original article

Tags:

Previous Article

Reset Pharma partners with Filament to license psilocybin drug

Next Article

Otsuka Pharmaceutical agrees to buy Mindset Pharma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Avadel Pharmaceuticals gets grant for patent granted for modified release formulation of gamma-hydroxybutyrate

Avadel Pharmaceuticals gets grant for patent granted fo...

Jun 8, 2024

STAT+: Michigan bill that would pare back pharma liability shield law moves closer to enactment

STAT+: Michigan bill that would pare back pharma liabil...

Nov 13, 2023

Scientists push for ‘greener’ drugs in published study

Scientists push for ‘greener’ drugs in published study

Jun 6, 2024